Goodwill and Intangible Assets (Tables)

9 Months Ended

Mar. 31, 2016

Goodwill and Intangible Assets

Schedule of changes in the carrying amount of goodwill

(In thousands)	Generic Pharmaceuticals
Balance at June 30, 2015	$	141
Goodwill acquired	313,310
Balance at March 31, 2016	$	313,451

Summary of intangible assets, net

	Weighted	Gross Carrying Amount				Accumulated Amortization						Intangible Assets, Net
(In thousands)	Avg. Life (Yrs.)	March 31, 2016		June 30, 2015		March 31, 2016			June 30, 2015			March 31, 2016		June 30, 2015
Definite-lived:
Cody Labs import license	15	$	582	$	582	$	(299	)	$	(269	)	$	283	$	313
KUPI product rights	15	430,000		—		(10,073		)	—			419,927		—
KUPI trade name	2	2,920		—		(513		)	—			2,407		—
KUPI other intangible assets	15	19,000		—		(445		)	—			18,555		—
Silarx product rights	15	10,000		10,000		(555		)	(56		)	9,445		9,944
Other product rights	14	653		653		(301		)	(269		)	352		384
Total definite-lived		$	463,155	$	11,235	$	(12,186	)	$	(594	)	$	450,969	$	10,641
Indefinite-lived:
KUPI in-process research and development	—	$	129,000	$	—	$	—		$	—		$	129,000	$	—
Silarx in-process research and development	—	18,000		18,000		—			—			18,000		18,000
Other product rights	—	449		449		—			—			449		449
Total indefinite-lived		147,449		18,449		—			—			147,449		18,449
Total intangible assets, net		$	610,604	$	29,684	$	(12,186	)	$	(594	)	$	598,418	$	29,090

Summary of future annual amortization expense

(In thousands) Fiscal Year Ending June 30,	Annual Amortization Expense
2016	$	8,035
2017	32,142
2018	31,264
2019	30,679
2020	30,672
Thereafter	318,177
	$	450,969